ImageneBio Inc

NASDAQ:IMA

Biotechnology

Healthcare
$4.61 +6.06%

+$0.35 today

Market cap
$52.00M
Beta
0.72
P/E (TTM)
-1.5
EPS (TTM)
-$4.02
52W Low $3.94High $18.00

Volume 0.00M

Average 0.35M

Balance Sheet

Inspect the capital base behind the business.

Assets

$152.98M

FY 2025 · Annual

+8.1% YoY

Liabilities

$19.84M

FY 2025 · Annual

+27.4% YoY

Equity

$133.14M

FY 2025 · Annual

+5.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents232.22M59.92M119.89M39.39M34.97M
Short-term Investments097.03M55.57M84.99M40.82M
Net Receivables00001.3M
Inventory00000
Other Current Assets629K964K1.15M2.78M63.21M
Total Current Assets236.52M160.01M178.66M127.17M140.29M
Property, Plant & Equipment (Net)8.98M8.46M8.02M4.23M790K
Goodwill00000
Intangible Assets00000
Long-term Investments2.39M0000
Tax Assets00000
Other Non-current Assets03.79M5.41M10.11M11.9M
Total Non-current Assets11.36M12.25M13.43M14.34M12.69M
Total Assets247.88M172.26M192.09M141.51M152.98M
Account Payables2.38M2.09M2.07M897K1.44M
Short-term Debt00000
Tax Payables00000
Deferred Revenue17.1M9.16M000
Other Current Liabilities2.84M5.11M3.4M1.75M7.53M
Total Current Liabilities27.19M21.5M14.21M10.78M11.23M
Long-term Debt00007.02M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)7.68M0000
Other Non-current Liabilities00950K1.06M870K
Total Non-current Liabilities12.81M3.79M8.13M4.8M8.6M
Total Liabilities40M25.29M22.34M15.58M19.84M
Common Stock36K36K48K48K11K
Retained Earnings(145.45M)(214.22M)(282.39M)(331.62M)(230.05M)
Accumulated OCI0(763K)(48K)68K87K
Other Stockholders Equity00000
Minority Interest00000
Total Equity207.88M146.97M169.76M125.93M133.14M
Total Debt6.99M5.69M10.74M7.52M10M
Net Debt(225.23M)(54.23M)(109.16M)(31.87M)(24.97M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$76.0M
Short-term Investments$41.2M
Other Current$4.8M
Total Current Assets$122.0M
PP&E (Net)$616.0K
Other Non-current$14.1M
Total Non-current Assets$14.7M
Total Assets$136.7M

Analysis

Selected assets total $136.7M for Latest. The largest visible component is Cash & Equivalents at $76.0M, about 55.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipAug 17, 2026
4Statement of changes in beneficial ownershipAug 17, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
EFFECTEFFECT filingAug 11, 2026
EFFECTEFFECT filingAug 11, 2026

How much cash does IMA have?

ImageneBio Inc (IMA) reported $34.97M in cash and equivalents in fiscal 2025.

How much debt does IMA carry?

ImageneBio Inc (IMA) reported $9.99M of total debt, with net debt of -$24.97M.